Stem Cell Therapeutics: Moving Ahead With Cancer Stem Cell Target – Investing.com
|
Stem Cell Therapeutics: Moving Ahead With Cancer Stem Cell Target
Investing.com Stem Cell Therapeutics Corp., (SSS) is advancing SIRPαFc, an anti-CD47 fusion protein targeting cancer stem cells (CSCs) and bulk tumour cells (BTCs) in acute myeloid leukaemia (AML). SCT raised C$33m in capital in late 2013 to fund SIRPαFc … |
